GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) and the GIP/GLP-1 dual agonist tirzepatide were studied in STEP (semaglutide, NEJM 2021), SURMOUNT (tirzepatide, NEJM 2022), and SURMOUNT-OSA (tirzepatide for obstructive sleep apnea, NEJM 2024)
The information we provide to our patients is based on the information provided by the manufacturer of the medication
Biology of Parkinsons disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorder
Researchers reported that Wegovy showed the strongest association with ION among semaglutide based GLP-1 drugs analyzed in the study, which was published in the British Journal of Ophthalmology
Plant-derived bioactive compounds exhibit strong therapeutic potential owing to their antioxidant, anti-inflammatory, and antimicrobial properties
However, metabolic instability during active disease or treatment adjustment periods may complicate the assessment of Saxenda's effectiveness and tolerability